EUVIMEDEUVIMED entdecken
Open Access

Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy

Takafumi Kabuto, Toshi Menju, Shigeto Nishikawa, Kazuhiro Terada, Akihiko Yoshizawa, Hiroshi Date

Annals of Thoracic and Cardiovascular Surgery · 2026 · 32 (1) · n/a

DOI: 10.5761/atcs.oa.25-00242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Takafumi Kabuto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Kyoto, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Neoadjuvant Therapy, Chemoradiotherapy, Adjuvant. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We investigated the clinical significance of lymphovascular invasion (LVI) in locally advanced lung adenocarcinoma after induction chemoradiotherapy (CRT).

Methods

We retrospectively reviewed patients with completely resected lung adenocarcinoma after induction CRT from 2007 to 2021 at our institution. We evaluated the effects of LVI on recurrence-free survival (RFS) and overall survival (OS).

Results

Fifty-six patients were included. The reasons for induction CRT were superior sulcus tumor (n = 11, 19.6%), direct invasion of other organs (n = 7, 12.5%), bulky N1 (n = 3, 5.4%), and N2 (n = 35, 62.5%). A pathological complete response was observed in 6 patients (10.7%). LVI was present in 14 patients (25.0%) and absent in 42 (75.0%). The LVI-positive group had significantly worse 5-year RFS (7.8% vs. 49.7%, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungNeoadjuvant TherapyChemoradiotherapy, AdjuvantChemoradiotherapyHumansFemaleRetrospective StudiesMaleMiddle AgedAgedNeoplasm InvasivenessTime FactorsRisk FactorsLymphatic MetastasisPneumonectomyRisk AssessmentAdultNeoplasm StagingPathologic Complete ResponseTreatment Outcome

Stichwörter der Autor:innen

induction chemoradiotherapylocally advanced lung cancerlymphovascular invasion

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Kyoto, Japan.
  • Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan.
  • Department of Diagnostic Pathology, Toyooka Public Hospital, Toyooka, Hyogo, Japan.
  • Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Kyoto, Japan.
  • Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara, Japan.
  • Division of Thoracic Surgery, Duke University Medical Center, Durham, NC, USA.

Zitieren

APA

Kabuto, T., Menju, T., Nishikawa, S., Terada, K., Yoshizawa, A., & Date, H. (2026). Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy. Annals of Thoracic and Cardiovascular Surgery, 32(1), n/a. https://doi.org/10.5761/atcs.oa.25-00242

Vancouver

Kabuto T, Menju T, Nishikawa S, Terada K, Yoshizawa A, Date H. Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy. Annals of Thoracic and Cardiovascular Surgery. 2026;32(1):n/a. doi:10.5761/atcs.oa.25-00242

BibTeX
@article{Kabuto2026,
  author = {Kabuto, Takafumi and Menju, Toshi and Nishikawa, Shigeto and Terada, Kazuhiro and Yoshizawa, Akihiko and Date, Hiroshi},
  title = {Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy},
  journal = {Annals of Thoracic and Cardiovascular Surgery},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {n/a},
  doi = {10.5761/atcs.oa.25-00242}
}
Kostenlos starten →